Aug 9, 2023 04:05PM
May 10, 2023 04:05PM
Mar 23, 2023 04:05PM
Mar 23, 2023 04:05PM
Nov 9, 2022 04:05PM
Nov 9, 2022 04:05PM
Aug 10, 2022 04:05PM ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update
Aug 10, 2022 04:05PM
May 11, 2022 04:05PM
May 11, 2022 04:05PM
Mar 24, 2022 04:10PM
Mar 24, 2022 04:05PM
Mar 24, 2022 04:05PM
Jan 19, 2022 07:04AM ADMA Biologics (ADMA) Prelim. Q4 Revenue Tops Consensus
Jan 19, 2022 07:00AM
Jan 19, 2022 07:00AM
Dec 21, 2021 07:10AM
Dec 21, 2021 07:00AM
Dec 21, 2021 07:00AM
Nov 10, 2021 04:01PM
Nov 10, 2021 04:01PM ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
Sep 2, 2021 07:00AM
Sep 2, 2021 07:00AM
Sep 9, 2020 07:00AM
Sep 9, 2020 07:00AM
Aug 24, 2020 09:31AM
Feb 24, 2020 07:00AM
Feb 24, 2020 07:00AM ADMA Biologics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection with Its Public Offering of Common Stock
Feb 7, 2020 06:10AM
Feb 7, 2020 06:09AM
Feb 6, 2020 08:41PM
Feb 6, 2020 08:40PM
Feb 6, 2020 04:09PM
Feb 6, 2020 04:06PM
Feb 6, 2020 04:06PM ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock
Feb 6, 2020 04:06PM
Nov 14, 2017 09:21AM

211,042 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All